Oramed Pharmaceuticals Parties Intend For JV To Initiate Phase 3 Oral Insulin Trial In The U.S.; Oramed Will Be Entitled To Receive A 3% Royalty On Gross Revenues Of JV Generated From Oramed Related Assets
Oramed製藥雙方打算讓合資企業在美國啓動3期口服胰島素試驗；Oramed將有權從Oramed相關資產產生的合資企業總收入中獲得3％的特許權使用費